RNR Healthcare News Releases

RNR Healthcare, Led by CEO Vicky Ramancha, to Open Pharmaceutical Trading Entity in the US

Mon, 09 Oct 2023 10:00:00 -0400

New York, New York--(Newsfile Corp. - October 9, 2023) - RNR Healthcare CEO Vicky Ramancha has announced to be entering USA market with pharmaceutical licensed trading entity. RNR Healthcare is currently under process of acquiring pharmaceutical license and will be opening up offices and operational units in the US to be estimated in the first quarter of 2024. Vicky Ramancha, Chief Executive Officer of RNR Healthcare To view an enhanced version of this graphic, please...

RNR Healthcare to Expand Business to Africa and Asia

Thu, 21 Sep 2023 11:22:00 -0400

New York, New York--(Newsfile Corp. - September 21, 2023) - RNR Healthcare's CEO Vicky Ramancha announced today that RNR Healthcare is targeting to expand the firm's activities to Far East, South East Asia Pacific, and African markets.Vicky Ramancha, CEO of RNR HealthcareTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10000/181382_d3c4f13ce4b1d8ed_001full.jpgThe company has already established presence in the Middle East with a capable and...

RNR Healthcare, Led by CEO Vicky Ramancha, Pursuing Global Market Entry

Thu, 21 Sep 2023 07:22:00 -0400

Hong Kong, Hong Kong--(Newsfile Corp. - September 21, 2023) - RNR Healthcare's Chief Executive Officer Vicky Ramancha announces push for the company's global market entry. The firm is already managing international clients and Vicky Ramancha is pursuing visibility and brand awareness expansion in the Asia Pacific and African markets.Vicky Ramancha, Chief Executive Officer of RNR HealthcareTo view an enhanced version of this graphic, please...

RNR Healthcare to Use Artificial Intelligence for Pharma Product Manufacturing

Tue, 19 Sep 2023 17:43:00 -0400

New York, New York--(Newsfile Corp. - September 19, 2023) - RNR Healthcare's CEO Vicky Ramancha is looking to connect artificial intelligence with pharmaceutical manufacturing process. Vicky Ramancha has announced that the company is looking to enter IPO consideration in 2025 with a vision to develop an advanced manufacturing facility for pharmaceutical products that can be used for rapid production while keeping product's IP safe and unleaked, which is all going to be supervised by AI.CEO,...